Construct a new manufacturing plant in the U.S
Delivered by the deadline
AI-assessed · human review in progress Found and assessed by AI from the cited sources. Shown with its evidence; it is not counted in any Kept Score until confirmed.
- Announced
- 1 Feb 2018
- Due
- 1 Feb 2023
- Delivered
- March 2022
- Deadline
- Met
- Late
- Not met
- Today
What the company said
“This investment includes committing up to $300 million to build a new manufacturing plant in the U.S.”
What we found
Evidence strength A What the grades mean
Amgen broke ground on a new drug substance manufacturing plant in North Carolina in March 2022, fulfilling the commitment to construct a new U.S. manufacturing plant within the five-year timeframe.
-
A Amgen Inc. 10-K filed 2023-02-09
“In March 2022, we broke ground to build a drug substance plant in North Carolina that will increase our manufacturing network capacity.” ✓ confirmed on the page
Market reaction: the shares moved +0.9% against the S&P 500 over the three sessions around the disclosure (8 Feb 2023 to 13 Feb 2023). What this measures
Checked 29 Sep 2026.
Commitment DNA
The structured record of this commitment. Fields the company did not state are left blank rather than guessed.
- Event type
- Facility other
- Indicative materiality
- Medium rules
- Action
- Construct
- Deliverable
- New U.S. manufacturing plant
- Amount
- USD 300
- Where
- U.S.
- In the company’s control
- High
- Specificity
- Medium
How this entry was checked
- Commitment recordedThe company's words were matched word for word against the filing.
- First checkAn AI model, Gemini (Google), read the company's later filings and recorded the outcome with a quoted passage.
- Second check: agreesA different AI model, Claude (Anthropic), re-read the evidence without being told the outcome and reached the same answer.
Not yet confirmed. Shown on the record, but it will not count in any score until it is confirmed. How verification works
Are you Amgen Inc.? You can publish an official statement next to this entry, free. Add a statement.
Is something here wrong or out of date? Companies and readers can ask us to check it. Please bring a link to a public source.
Report an error in this entry Reference: KI-C-2018-AMGN-001020 · Corrections policy